4//SEC Filing
OBrien Christopher Flint 4
Accession 0001209191-18-004246
CIK 0000914475other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:12 PM ET
Size
5.6 KB
Accession
0001209191-18-004246
Insider Transaction Report
Form 4
OBrien Christopher Flint
Sr. VP & Chief Medical Officer
Transactions
- Sale
Common Stock
2018-01-16$79.14/sh−1,750$138,499→ 50,723 total
Footnotes (2)
- [F1]Sale of 1,750 shares of common stock issued upon vesting of 3,500 restricted stock units on January 16, 2018 to cover payroll and withholding taxes, with the balance of the shares (1,750) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $76.09 to $82.04. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
Related Parties
1- filerCIK 0001343124
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 4:12 PM ET
- Size
- 5.6 KB